Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Myocardial Disease
Antioxidant, EUK-8, Prevents Murine Dilated Cardiomyopathy
Satoru KawakamiAkina MatsudaTadahiro SunagawaYoshihiro NodaTakao KanekoShoichi TaharaYoshimi HiraumiSouichi AdachiHiromitsu MatsuiKatsuyuki AndoToshiro FujitaNaoki MaruyamaTakuji ShirasawaTakahiko Shimizu
Author information
JOURNAL FREE ACCESS

2009 Volume 73 Issue 11 Pages 2125-2134

Details
Abstract

Background: Mice lacking manganese-superoxide dismutase (Mn-SOD) activity exhibit the typical pathology of dilated cardiomyopathy (DCM). In the present study, presymptomatic and symptomatic mutant mice were treated with the SOD/catalase mimetic, EUK-8. Methods and Results: Presymptomatic heart/muscle-specific Mn-SOD-deficient mice (H/M-Sod2-/-) were treated with EUK-8 (30 mg · kg-1 · day-1) for 4 weeks, and then cardiac function and the reactive oxygen species (ROS) production in their heart mitochondria were assessed. EUK-8 treatment suppressed the progression of cardiac dysfunction and diminished ROS production and oxidative damage. Furthermore, EUK-8 treatment effectively reversed the cardiac dilatation and dysfunction observed in symptomatic H/M-Sod2-/- mice. Interestingly, EUK-8 treatment repaired a molecular defect in connexin43. Conclusions: EUK-8 treatment can prevent and cure murine DCM, so SOD/catalase mimetic treatment is proposed as a potential therapy for DCM. (Circ J 2009; 73: 2125-2134)

Content from these authors
© 2009 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top